ERA-NET JPIAMR-ACTION Call for Joint Transnational Research Proposals (2021) “One Health interventions to prevent or reduce the development and transmission of antimicrobial resistance (AMR)”
The European One Health Action Plan against AMR encourages the EU and its Member States to deliver innovative, effective and sustainable responses to AMR, especially to reduce the emergence and spread of AMR inside and outside the EU. This call, funded under the ERA-NET JPIAMR-ACTION, is the 13th JPIAMR transnational call for research projects.
This call advocates for a One Health approach. Proposals should focus on at least two One Health settings (human, animal, environment).
Projects should be implemented into relevant geographic areas, including into resource-limited settings, with a One Health perspective. Projects are encouraged to include transdisciplinary research teams, in which involvement of the social sciences is also encouraged. Low and middle income country (LMIC) led collaborations at global and regional level are welcomed.
- Details of this scheme
This call, funded under the ERA-NET JPIAMR-ACTION, is the 13th JPIAMR transnational call for research projects, advocates for a One Health approach to focus on tackling the rising threat of antibiotic resistance.
The scope of this call includes:
- Understand the impact of interventions on the development and transmission of antibiotic resistance in, and or between, at least two One Health Settings.
- Design, implement, evaluate, and compare interventions that will have a true impact on preventing or reducing the development and transmission of antibiotic resistance in and/or between at least two One Health Settings.
The following sub-topics are out of scope of the call:
- Proposals not primarily focusing on antibiotic resistance.
- Proposals limited to implementing existing interventions to new countries without any research objectives.
- Development of new antimicrobial drugs or investigations on new targets for the development of antimicrobial drugs.
- Proposals solely developing diagnostic tools to monitor selection or transmission of antibiotic resistance.
- Proposals aiming to improve existing commercially exploited technologies or products.
- Proposals solely aiming to develop or implement surveillance systems.
Under HRB national rules the following additional eligibility criteria apply:
- The scope of the call includes only "Understand the impact of interventions on the development and transmission of antibiotic resistance in, and/or between, at least two One Health settings".
- Proposals addressing “Design, implement, evaluate, and/or compare innovative interventions that will have a true impact on preventing or reducing the development and transmission of antibiotic resistance in and/or between at least two One Health settings" are ineligible.
- Proposals must include human health, meaning they must focus on human health and environmental health and/or animal health. Irish applicants planning an application covering animal and human health are advised to consider where the balance of activity lies when choosing which Irish funder they apply to (HRB or DAFM). Please contact the funders in case of doubt ahead of submission.
- Who can apply?
This is a joint transnational call: applicants must apply as part of a transnational consortium.
Researchers from Ireland can apply as coordinators or partners. If successful, researchers from Ireland will be funded by the Health Research Board up to the maximum amount for the call. Applicants applying for funding from Ireland must be based at an eligible HRB Host Institution.
The following conditions apply to the composition of consortia:
- Minimum of 3 partners from 3 different participating countries.
- Maximum of 6 partners (including non-funding partners)
- Individual country partners/coordinators should confirm eligibility with their national funding organisation contact point.
- How to apply
- Apply for this award
- Contact us
General Queries: Joint Call Secretariat (JCS)
French National Research Agency
Applicants from Ireland who still have questions after reading the information on the Call website and the HRB Guidance notes and HRB FAQ can contact Dr Louise Drudy at HRB email:ldrudy(at)hrb.ieClose